Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Broadcom
AVGO
|
+$67.3M |
| 2 |
Veralto
VLTO
|
+$60.2M |
| 3 |
Newmont
NEM
|
+$43.4M |
| 4 |
Vertiv
VRT
|
+$19.4M |
| 5 |
Webster Financial
WBS
|
+$17.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$328M |
| 2 |
Microsoft
MSFT
|
+$244M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$237M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$109M |
Sector Composition
| 1 | Technology | 30.91% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.36% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PTC Therapeutics
PTCT
$4.85B
| $3.68M | ﹤0.01% |
133,565
-13,200
| -9% | -$364K |
|
|
CBAY
1477
DELISTED
Cymabay Therapeutics
CBAY
| $3.67M | ﹤0.01% |
155,400
-26,100
| -14% | -$616K |
|
1478
WesBanco
WSBC
$3.03B
| $3.67M | ﹤0.01% |
116,945
-13,300
| -10% | -$417K |
|
|
GRP.U
1479
Granite Real Estate Investment Trust
GRP.U
$3.43B
| $3.66M | ﹤0.01% |
63,500
-5,400
| -8% | -$311K |
|
1480
Sylvamo
SLVM
$1.75B
| $3.65M | ﹤0.01% |
74,300
-10,000
| -12% | -$491K |
|
1481
Andersons Inc
ANDE
$1.38B
| $3.64M | ﹤0.01% |
63,250
-7,200
| -10% | -$414K |
|
1482
RLJ Lodging Trust
RLJ
$1.15B
| $3.64M | ﹤0.01% |
310,358
-39,500
| -11% | -$463K |
|
1483
Victoria's Secret
VSCO
$2.12B
| $3.64M | ﹤0.01% |
137,000
-16,500
| -11% | -$438K |
|
1484
Lumen
LUMN
$6.21B
| $3.64M | ﹤0.01% |
1,986,500
-221,000
| -10% | -$404K |
|
1485
Banner Corp
BANR
$2.29B
| $3.63M | ﹤0.01% |
67,700
-7,800
| -10% | -$418K |
|
1486
Telephone and Data Systems
TDS
$4.51B
| $3.62M | ﹤0.01% |
197,100
-22,500
| -10% | -$413K |
|
|
DQ
1487
Daqo New Energy
DQ
$1.73B
| $3.61M | ﹤0.01% |
135,712
| – | – |
|
1488
Laureate Education
LAUR
$4.33B
| $3.61M | ﹤0.01% |
263,300
-30,400
| -10% | -$417K |
|
1489
Beam Therapeutics
BEAM
$2.08B
| $3.61M | ﹤0.01% |
132,600
-9,800
| -7% | -$267K |
|
1490
MaxLinear
MXL
$1.37B
| $3.61M | ﹤0.01% |
151,673
-15,400
| -9% | -$366K |
|
1491
Iovance Biotherapeutics
IOVA
$821M
| $3.57M | ﹤0.01% |
439,456
-49,900
| -10% | -$406K |
|
1492
Virtu Financial
VIRT
$3.1B
| $3.57M | ﹤0.01% |
176,100
-23,200
| -12% | -$470K |
|
1493
Central Garden & Pet Class A
CENTA
$2.03B
| $3.56M | ﹤0.01% |
101,000
-12,500
| -11% | -$440K |
|
1494
Upwork
UPWK
$2.24B
| $3.56M | ﹤0.01% |
239,300
-24,800
| -9% | -$369K |
|
1495
Dynavax Technologies
DVAX
$1.1B
| $3.55M | ﹤0.01% |
253,878
-28,500
| -10% | -$398K |
|
1496
Hillman Solutions
HLMN
$1.92B
| $3.54M | ﹤0.01% |
383,900
-43,700
| -10% | -$402K |
|
1497
Mirion Technologies
MIR
$5.24B
| $3.52M | ﹤0.01% |
343,600
-39,600
| -10% | -$406K |
|
1498
Federal Agricultural Mortgage
AGM
$2.15B
| $3.51M | ﹤0.01% |
18,381
-2,100
| -10% | -$402K |
|
|
SIX
1499
DELISTED
Six Flags Entertainment Corp.
SIX
| $3.51M | ﹤0.01% |
139,900
-15,700
| -10% | -$394K |
|
1500
Triumph Financial, Inc.
TFIN
$1.4B
| $3.5M | ﹤0.01% |
43,600
-5,200
| -11% | -$417K |
|